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chemotaxis and cell differentiation, at least in part, via
mitochondria in D. discoideum
Yuzuru Kubohara1,2,*, Haruhisa Kikuchi3, Van Hai Nguyen3, Hidekazu Kuwayama4 and Yoshiteru Oshima3
ABSTRACT
Differentiation-inducing factor-1 [1-(3,5-dichloro-2,6-dihydroxy-4-
methoxyphenyl)hexan-1-one (DIF-1)] is an important regulator of
cell differentiation and chemotaxis in the development of the cellular
slime mold Dictyostelium discoideum. However, the entire signaling
pathways downstream of DIF-1 remain to be elucidated. To
characterize DIF-1 and its potential receptor(s), we synthesized two
fluorescent derivatives of DIF-1, boron-dipyrromethene (BODIPY)-
conjugated DIF-1 (DIF-1-BODIPY) and nitrobenzoxadiazole (NBD)-
conjugated DIF-1 (DIF-1-NBD), and investigated their biological
activities and cellular localization. DIF-1-BODIPY (5 µM) and DIF-1
(2 nM) induced stalk cell differentiation in the DIF-deficient strain
HM44 in the presence of cyclic adenosine monosphosphate (cAMP),
whereas DIF-1-NBD (5 µM) hardly induced stalk cell differentiation
under the same conditions. Microscopic analyses revealed that the
biologically active derivative, DIF-1-BODIPY, was incorporated by
stalk cells at late stages of differentiation and was localized to
mitochondria. The mitochondrial uncouplers carbonyl cyanide m-
chlorophenylhydrazone (CCCP), at 25–50 nM, and dinitrophenol
(DNP), at 2.5–5 µM, induced partial stalk cell differentiation in HM44
in the presence of cAMP. DIF-1-BODIPY (1–2 µM) and DIF-1
(10 nM), as well as CCCP and DNP, suppressed chemotaxis in the
wild-type strain Ax2 in shallow cAMP gradients. These results
suggest that DIF-1-BODIPY and DIF-1 induce stalk cell
differentiation and modulate chemotaxis, at least in part, by
disturbing mitochondrial activity.
KEYWORDS:Dictyostelium discoideum, DIF-1, DIF-2, Mitochondria,
Cell differentiation, Chemotaxis
INTRODUCTION
The vegetative amebae of the cellular slime mold Dictyostelium
discoideum feed on bacteria. Starvation initiates morphogenesis:
cells gather to form a slug-shaped multicellular aggregate and
differentiate into two distinct types (prespore and prestalk), which
eventually form a fruiting body consisting of spores and a
multicellular stalk. Because of the simple pattern of its life cycle
(cell differentiation and morphogenesis), D. discoideum is an
excellent model in cell and developmental biology (Annesley and
Fisher, 2009) (http://dictybase.org/).
Cyclic adenosine monosphosphate (cAMP) and the chlorinated
polyketides differentiation-inducing factor-1 [1-(3,5-dichloro-
2,6-dihydroxy-4-methoxyphenyl)hexan-1-one (DIF-1)] and
differentiation-inducing factor-2 [1-(3,5-dichloro-2,6-dihydroxy-
4-methoxyphenyl)pentan-1-one (DIF-2)] (Fig. 1A) play pivotal
roles in the development of D. discoideum. While extracellular
cAMP secreted by differentiating cells is essential for both
prespore and prestalk cell differentiation, it also acts as a
chemoattractant when cells gather to form the multicellular
aggregate (Konijn et al., 1967; Bonner, 1970; Darmon et al.,
1975; Kay, 1982). Initially, DIF-1 and DIF-2 were identified as
inducers of stalk cell differentiation in vitro in the presence of
cAMP (Town et al., 1976; Morris et al., 1987, 1988; Kay et al.,
1989, 1999). The activity of DIF-1 is 2.5 times that of DIF-2 in
in vitro assay with strains derived from V12M2, a wild-type strain
(Kay et al., 1999; Masento et al., 1988). Differentiation-inducing
factor-3 [1-(3-chloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-
one (DIF-3)] (Fig. 1A) is the first metabolite produced during
the degradation of DIF-1 and has virtually no activity in the
induction of stalk cell differentiation in D. discoideum (Morris
et al., 1988; Kay et al., 1989).
DIF-1 might function, at least in part, via increases in cytosolic
calcium or proton concentrations (Kubohara and Okamoto, 1994;
Schaap et al., 1996; Azhar et al., 1997; Kubohara et al., 2007; Lam
et al., 2008). Several transcription factors, such as the basic-leucine
zipper transcription factors, DimA and DimB, are involved in DIF-
1 signaling (Thompson et al., 2004; Huang et al., 2006;
Zhukovskaya et al., 2006; Keller and Thompson, 2008). In
shallow cAMP gradients, DIF-1 inhibits chemotaxis via the
phosphodiesterase GbpB, whereas DIF-2 stimulates chemotaxis
via the phosphodiesterase RegA (Kuwayama and Kubohara, 2009;
Kuwayama et al., 2011). The mechanisms by which DIFs modulate
chemotaxis differ, at least in part, from those they use to induce stalk
cell differentiation (Kuwayama and Kubohara, 2009, 2016;
Kuwayama et al., 2011). Despite the importance of DIF-1 and
DIF-2 in D. discoideum development, the entire signaling pathways
they activate, including receptors, remain to be identified.
To elucidate the mechanisms underlying the effects of DIF-1 (and
possibly DIF-2), we synthesized two fluorescent derivatives of
DIF-1, boron-dipyrromethene (BODIPY)-conjugated DIF-1 (DIF-1-
BODIPY) and nitrobenzoxadiazole (NBD)-conjugated DIF-1
(DIF-1-NBD) (Fig. 1B,C), and investigated their localization and
function in D. discoideum cells. We show that DIF-1-BODIPY, but
not DIF-1-NBD, is bioactive and appears to function similarly toReceived 19 August 2016; Accepted 4 April 2017
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DIF-1: this derivative induces stalk cell formation in vitro in the
presence of cAMP inHM44 (a DIF-deficient strain) (Kopachik et al.,
1983) and suppresses chemotaxis of cells of thewild-type strain Ax2
in shallow cAMP gradients. We also show that DIF-1-BODIPY is
undetectable inside the cells during an early stage of development but
is localized to intracellular organelles, mainlymitochondria, during a
later developmental stage.We examined the effects of DIF-1, DIF-1-
BODIPY, and the mitochondrial uncouplers dinitrophenol (DNP)
and carbonyl cyanide m-chlorophenylhydrazone (CCCP), and the
results suggest that DIF-1 (and DIF-1-BODIPY) induces stalk cell
differentiation and modulates chemotaxis, at least in part, via
mitochondria.
RESULTS
Synthesis of fluorescent derivatives of DIF-1 and assay of
stalk cell induction
The synthetic schemes of DIF-1-BODIPY and DIF-1-NBD are
shown in Fig. 1B,C. We also synthesized the control compound
butyl-BODIPY (Bu-BODIPY) (Kubohara et al., 2013). The effects
of DIF-1, DIF-2, and the fluorescent compounds on in vitro stalk cell
Fig. 1. Chemical structures of DIF-1 and related compounds. (A) Chemical structures of DIFs, Bu-BODIPY and BODIPY-DIF-3. Molecular weight (MW) and
CP for each compound are provided in parentheses. (B,C) Synthetic schemes of DIF-1-BODIPY and DIF-1-NBD. See Materials and Methods section for details.
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differentiation in the DIF-deficient strain HM44 are shown in Fig. 2.
Even in the presence of cAMP, HM44 cells cannot differentiate into
stalk cells in vitro unless exogenous DIF is supplied; therefore,
HM44 cells are suitable for the assay of stalk cell induction by
DIF-like molecules (Kopachik et al., 1983; Kubohara et al., 1993;
Kubohara andOkamoto, 1994). As expected, DIF-1 or DIF-2 (2 nM)
induced stalk cell formation in HM44 in the presence of cAMP;
DIF-1-BODIPY (0.1–5 µM) dose-dependently induced stalk cell
formation in up to 60%–80% of the cells under the same conditions
(Fig. 2). By contrast, neither Bu-BODIPY (5 µM) nor DIF-1-NBD
(0.1–5 µM) induced any stalk cell formation (Fig. 2).
Cellular localization of DIF-1-BODIPY during in vitro stalk cell
differentiation
We next compared the cellular localization of DIF-1-BODIPY and
DIF-1-NBD in HM44 cells. After 1-h starvation (incubation), cells
were ameboid and were hardly stained with DIF-1-BODIPY or DIF-
1-NBD (Fig. 3A), whereas cells fixed with formalin after starvation
were stained well with the bioactive derivative DIF-1-BODIPY, but
not with the nonbioactive derivative DIF-1-NBD (Fig. 3B).
We then compared cellular localization of DIF-1-BODIPY and
the nonbioactive control compound Bu-BODIPY during in vitro
differentiation of HM44 cells. After 1-h starvation (incubation),
cells were hardly stained with DIF-1-BODIPY (Fig. 4A). After 20-h
incubation with cAMP and DIF-1-BODIPY, cells were still
ameboid; some of them had formed aggregates, in which some
cells were stained with DIF-1-BODIPY, and there was
heterogeneity among the cells (Fig. 4C). At 28 h, cells had begun
to differentiate into stalk cells; one or more autophagic vacuoles had
formed in each cell, each cell had formed a cell wall, and many cells
were stained with DIF-1-BODIPY to a variable extent (Fig. 4E). At
48 h, most cells had differentiated into stalk cells and were stained
with DIF-1-BODIPY; the signal was stronger in cytoplasmic
regions than in autophagic vacuoles (Fig. 4G). However, cells fixed
with formalin were stained with DIF-1-BODIPY at each time point
(Fig. 4B,D,F,G). These observations suggest that DIF-1-BODIPY
(and possibly DIF-1) is unable to penetrate into the cells or is
pumped out from the cells during the early phase, but not during
later phases, of cell differentiation. By contrast, Bu-BODIPY
neither induced stalk cell formation nor was detected in the cells at
any time point, even if they were fixed with formalin (Fig. 4). Taken
together, these results indicate that DIF-1-BODIPY can be used to
probe cellular uptake and localization of DIF-1.
Target organelle of DIF-1-BODIPY
It is noteworthy that DIF-1, DIF-3 and their derivatives possess anti-
tumor activities (Asahi et al., 1995; Kubohara, 1997, 1999; Gokan
et al., 2005), and that DIF-3 derivatives are more active than DIF-1
Fig. 2. Stalk-cell-inducing activities of DIF-1 and related compounds inHM44 cells. (A) Cells were incubated in vitro for 48 hwith 5 mMcAMP in the presence
of 0.2% DMSO, 2 nM DIF-1 or DIF-2, or the indicated concentrations of DIF-1-BODIPY or DIF-1-NBD, and the stalk cell population was assessed by phase-
contrast microscopy. (B) Cells were incubated in vitro for 48 h with 5 mM cAMP in the presence of 0.2%DMSO, 2 nMDIF-1 or DIF-2, or 5 µM DIF-1-BODIPY, Bu-
BODIPY or DIF-1-NBD, and the stalk cell population was assessed by using phase-contrast microscopy. Data are the mean±s.d. of three independent
experiments. *P<0.05; **P<0.01 (by one-tailed Welch’s t-test). (C) Representative photos of the cells in (B); arrowheads indicate stalk cells with a vacuole.
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derivatives in suppressing tumor cell growth (Gokan et al., 2005;
Kubohara, 1999). We have shown that the fluorescent derivative
BODIPY-DIF-3 (Fig. 1A) localizes to mitochondria in mammalian
cell lines (Kubohara et al., 2013, 2014). We thus compared
localization of DIF-1-BODIPY and MitoTracker (a probe for
mitochondria) in HM44 cells (Fig. 5). DIF-1-BODIPY co-localized
to mitochondria stained with MitoTracker in formalin-fixed cells
that had been starved for 1 h (Fig. 5A) or incubated for 21 h with
cAMP; in the latter case, most cells had formed small aggregates
(Fig. 5C). By contrast, Bu-BODIPY did not stain any organelles in
formalin-fixed cells (Fig. 5B,D). These results strongly suggest that
DIF-1-BODIPY (and possibly DIF-1) might function, at least in
part, by affecting mitochondrial activity in D. discoideum.
Effects of CCCP and DNP on stalk cell differentiation
We have recently shown that DIF-1 and its derivatives act as
mitochondrial uncouplers in mammalian cells (Kubohara et al.,
2013, 2015). To determine whether DIF-1 (and DIF-1-BODIPY)
induces stalk cell differentiation by affecting mitochondria in
D. discoideum, we examined the effects of CCCP and DNP on stalk
cell formation in HM44. As shown in Fig. 6, CCCP (25–50 nM) or
DNP (2.5–5 µM) weakly but significantly induced stalk cell
formation in the presence of cAMP; at higher concentrations, both
uncouplers were toxic to the cells (data not shown). The stalk-
inducing activities of CCCP and DNP did not exceed ∼10% and
∼20%, respectively (Fig. 6A); neither CCCP nor DNP showed
additive effects with DIF-1 at a low concentration (0.4 nM). These
results suggest that DIF-1 induces stalk cell differentiation partly by
uncoupling mitochondrial activity but also via another pathway.
Effects of DIF-1-BODIPY on chemotactic cell movement
To verify whether DIF-1-BODIPY inhibits chemotaxis (similar to
DIF-1) or stimulates chemotaxis (similar to DIF-2), we examined its
effects on chemotactic movement of Ax2 cells toward cAMP
(Fig. 7A). In shallow cAMP gradients, chemotaxis was suppressed
by 10 nM DIF-1 and promoted by 10 nM DIF-2, as previously
described (Kuwayama and Kubohara, 2009). Similar to DIF-1,
DIF-1-BODIPY (1–2 µM) suppressed chemotaxis (Fig. 7A).
To confirm that DIF-1-BODIPY can functionally mimic DIF-1,
we next compared their effects on chemotaxis in gbpB– cells.
Neither DIF-1 (10 nM) nor DIF-1-BODIPY (1–2 µM) affected
chemotaxis in shallow cAMP gradients, whereas DIF-2 (used as a
positive control) significantly promoted chemotaxis under the same
conditions (Fig. 7A), indicating that DIF-1-BODIPY and DIF-1
exert their effects via a GbpB-dependent pathway (Kuwayama and
Kubohara, 2009). Thus, DIF-1-BODIPY can functionally mimic
DIF-1 in the regulation of chemotaxis.
Effects of CCCP and DNP on chemotactic cell movement
To demonstrate that DIF-1 might function by disturbing
mitochondrial activity, we examined the effects of CCCP and
DNP on chemotactic cell movement toward cAMP (Fig. 7B). As
expected, CCCP (25–50 nM), DNP (5 µM) and DIF-1 (10 nM)
significantly suppressed chemotaxis of Ax2 cells in shallow cAMP
gradients but hardly affected chemotaxis of gbpB– cells (Fig. 7B).
These results indicate that all three compounds suppress chemotaxis
via a GbpB-dependent pathway and that DIF-1 (and possibly DIF-1-
BODIPY) might suppress chemotaxis in shallow cAMP gradients
by uncoupling mitochondrial activity.
Localization of DIF-1-BODIPY in aggregating Ax2 cells
Finally, we localized DIF-1-BODIPY in aggregating (chemotacting)
Ax2 cells under submerged conditions without exogenous cAMP;
under these conditions, cells formed streaming aggregates (Fig. S1).
After 3-h incubation, we still observed single ameboid cells; living
cells were not stained with DIF-1-BODIPY, although formalin-fixed
cells were clearly stained (Fig. S1A). At 15 h, cells formed
aggregates, in which a small fraction of the cells was clearly
stained with DIF-1-BODIPY; formalin-fixed cells were strongly
stained (Fig. S1B).
Fig. 3. Localization of DIF-1-BODIPYandDIF-1-NBD in living and formalin-fixedHM44 cells. (A) Cells were incubated in vitro for 1 h with 5 µMDIF-1-BODIPY
orDIF-1-NBD. (B)Cellswere incubated in vitro for 1 hwith no additives, fixedwith formalin, and stained for 0.5 hwith 5 µMDIF-1-BODIPYor DIF-1-NBD.Cellswere
washed free of the additives and observed under phase-contrast and fluorescence microscopes. Scheme of the experiment is indicated above each panel.
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Fig. 4. Localization of DIF-1-BODIPY and Bu-
BODIPY in living and formalin-fixed HM44 cells.
(A,B) Localization of DIF-1-BODIPY and Bu-
BODIPY in undifferentiated cells. (A) Cells were
incubated in vitro for 1 h with 5 µM DIF-1-BODIPY
(DIF-1-BOD) or Bu-BODIPY (Bu-BOD). (B) Cells
were incubated in vitro for 1 h without the additives,
fixed with formalin, and stained for 0.5 h with 5 µM
DIF-1-BODIPY or Bu-BODIPY. Cells were washed
free of the additives and observed under phase-
contrast and fluorescence microscopes. (C–F)
Localization of DIF-1-BODIPY and Bu-BODIPY in
differentiating cells. (C,E) Cells were incubated
in vitro for (C) 20 h or (E) 28 h with 5 mM cAMP in
the presence of 5 µM DIF-1-BODIPY or Bu-
BODIPY. (D,F) Cells were incubated for the same
time periods with 5 mM cAMP, fixed with formalin,
and stained for 0.5 h with 5 µM DIF-1-BODIPY or
Bu-BODIPY. Cells were washed and observed
under phase-contrast and fluorescence
microscopes. (G,H) Localization of DIF-1-BODIPY
and Bu-BODIPY in stalk cells. (G) Cells were
incubated in vitro for 48 h with 5 mM cAMP in the
presence of 5 µM DIF-1-BODIPY or Bu-BODIPY.
(H) Cells were incubated for the same time periods
with 5 mM cAMP, fixed with formalin, and stained
for 0.5 h with 5 µM DIF-1-BODIPY or Bu-BODIPY.
Cells were washed and observed under phase-
contrast and fluorescence microscopes. Scheme of
the experiment is indicated above each panel.
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Biological activities of DIF-1-BODIPY
In this study, we designed and synthesized the fluorescent DIF
derivative DIF-1-BODIPY (Fig. 1B) and found that DIF-1-
BODIPY (0.1–5 µM) induced stalk cell differentiation in the
presence of cAMP in the DIF-deficient strain HM44 (Fig. 2). DIF-1-
BODIPY (1–2 µM) also suppressed chemotaxis in shallow cAMP
gradients in Ax2 cells (Fig. 7). Although we do not exclude the
possibility that DIF-1-BODIPY at several micromolars might affect
cellular functions nonspecifically, the present results indicate that
DIF-1-BODIPY can mimic the effects of DIF-1 in D. discoideum.
Subcellular localization of DIF-1-BODIPY to mitochondria
The hydrophobic indices of DIF-1 [ClogP (CP), 4.21] and DIF-1-
BODIPY (CP, 5.85) (Fig. 1A,B) indicate that both compounds are
likely to penetrate the cell membrane. However, we found that DIF-
Fig. 5. Multi-color imaging of formalin-fixed HM44 cells. (A,B) Cells were incubated in vitro for 1 h with MitoTracker (0.2 µM) and fixed with formalin. Cells were
then stained for 0.5 h with Hoechst (1 µg ml−1) and (A) 5 µM DIF-1-BODIPY or (B) Bu-BODIPY, then washed and observed by using high-magnification
fluorescencemicroscopy. (C,D) Cells were incubated in vitro for 20 h with 5 mM cAMP, further incubated for 1 h with MitoTracker (0.2 µM), and fixed with formalin.
Cells were then stained for 0.5 h with Hoechst and (C) 5 µM DIF-1-BODIPY or (D) Bu-BODIPY, then washed and observed as above. Three-dimensional images
were constructed from z-stacked two-dimensional (2D) images; two representative 2D projections of the 3D images are shown. Nonlinear adjustment was
performed on 3D images to obtain clear high-contrast images. Note that DIF-1-BODIPY and MitoTracker co-localized to mitochondria.
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1-BODIPY was absent in cells at early stages of development but
gradually penetrated into or was taken up by cells differentiating to
stalk cells (Fig. 4). DIF-1-BODIPY localized to mitochondria
(Fig. 5). During early, but not late, stages of development, DIF-1-
BODIPY (and thus DIF-1) might be pumped out of cells (Fig. 8).
The molecular size of DIF-1-BODIPY is larger than that of DIF-1
and the hydrophobic indices of the two compounds are different
(Fig. 1A,B). However, because Bu-BODIPY was not detected in
any organelles (Figs 4 and 5), the mitochondrial localization of DIF-
1-BODIPY was not caused by the BODIPY moiety but likely
reflects localization of DIF-1.
DIFs and their derivatives possess anti-tumor activities when
tested on mammalian tumor cells, and derivatives of DIF-3 are more
potent anti-tumor agents than those of DIF-1 (Asahi et al., 1995;
Gokan et al., 2005; Kubohara, 1999; Takahashi-Yanaga et al., 2003;
Akaishi et al., 2004; Kubohara et al., 2015; Oladimeji et al., 2015).
The fluorescent DIF-3 derivative BODIPY-DIF-3 penetrates the
cell membrane, localizes to mitochondria, and suppresses cell
growth in some of the tumor cell lines tested (Kubohara et al., 2013,
2015). Bioactive DIF derivatives and the mitochondrial uncoupler
CCCP promote oxygen consumption in mitochondria isolated from
mouse liver; the anti-tumor activity of DIF derivatives might result,
at least in part, from their uncoupling activity in the mitochondria of
tumor cells (Kubohara et al., 2013, 2015). In D. discoideum, DIF-1
can disturb mitochondrial membrane potential and respiration,
suggesting that it might function as an uncoupler (Shaulsky
and Loomis, 1995), although the effective concentration range of
DIF-1 (0.1–1 µM) rather exceeded its putative physiological
concentrations (at most ∼0.1 µM; Kay, 1998). However, DIF-1 at
0.1 µMwas later shown to affect mitochondrial membrane potential
in Ax2 cells (Arnoult et al., 2001) and to promote mitochondrial
oxygen consumption and induce ATP depletion in an autophagy
mutant strain (Laporte et al., 2007; Giusti et al., 2009), suggesting
that it can act as an uncoupler at physiological concentrations. In the
present study, we have shown that the mitochondrial uncouplers
CCCP and DNP induce partial stalk differentiation of HM44 cells
(Fig. 6) and that the uncouplers and DIF-1 suppress chemotaxis in
Ax2 cells in shallow cAMP gradients (Fig. 7B). Taken together,
these data suggest that DIF-1 might function, at least in part, via
mitochondria (possibly as an uncoupler) in D. discoideum.
Unexpectedly, however, neither CCCP (25–50 nM) nor DNP
(2.5–5 µM) showed an additive effect with 0.4 nM DIF-1 on stalk
cell formation (Fig. 6). Although the cause of the absence of such
effect is unknown, DIF-1 might function via multiple signaling
cascades, only one of which may be mimicked by CCCP and DNP;
DIF-1 at 0.4 nM might be sufficient to saturate this pathway.
Alternatively, as CCCP >50 nM and DNP >5 µM were toxic to the
cells (data not shown), their toxicity might cancel their stalk-
inducing activity in the presence of DIF-1.
Biological activity and cellular localization of DIF-1-NBD
In the present study, we have also synthesized DIF-1-NBD, a
fluorescent amide derivative of DIF-1 (Fig. 1C). DIF-1-NBD was
expected to be a good probe for DIF-1 because some amide
derivatives of DIF-1 are excellent inducers of stalk cell differentiation
in HM44 cells (Kikuchi et al., 2008), and also because the molecular
size of DIF-1-NBD is much smaller than that of DIF-1-BODIPY and
its CP value (3.51) suggests that DIF-1-NBD can penetrate the cell
membrane (Fig. 1A). Unfortunately, however, DIF-1-NBD (5 µM)
neither induced stalk cell differentiation (Fig. 2) nor appeared to
localize to any parts of HM44 cells (Fig. 3). Although we cannot
exclude that the localization of DIF-1-BODIPY in mitochondria
reflects its non-specific binding because of its high concentration, the
absence of cell staining or activity of DIF-1-NBD (5 µM) and another
non-bioactive compound Bu-BODIPY (5 µM) (Figs 2–4) indicates
that it is likely that the biological activities and cellular localization of
DIF-1-BODIPY (5 µM) reflect those of DIF-1 at nanomolar
concentrations.
Proposed scheme for DIF-1 function
The functions of DIF-1 have been analyzed in many studies
(Kubohara and Okamoto, 1994; Schaap et al., 1996; Azhar et al.,
1997; Thompson et al., 2004; Huang et al., 2006; Zhukovskaya
et al., 2006; Kubohara et al., 2007; Lam et al., 2008; Keller and
Thompson, 2008; Luciani et al., 2009; Giusti et al., 2010). As we
have shown here the possible involvement of mitochondria in the
effects of DIF-1, we mainly discuss the relationship between DIF
signaling and mitochondria. We assume that DR1-D (putative DIF-
1 receptor responsible for the induction of cell differentiation)
(Fig. 8A) might mediate the induction of stalk cell differentiation by
DIF-1 (at least in part via increases in intracellular calcium and/or
proton concentrations) (Kubohara and Okamoto, 1994; Schaap
et al., 1996; Azhar et al., 1997; Kubohara et al., 2007; Lam et al.,
2008). In shallow cAMP gradients, DIF-1 suppresses chemotaxis
via a GbpB-dependent pathway, whereas DIF-2 promotes
Fig. 6. Effects of CCCP and DNP on stalk cell formation in HM44. (A) Cells
were incubated in vitro for 48 h with 5 mM cAMP in the presence of 0.2%
DMSO or the indicated concentrations of CCCP, DNP, and/or DIF-1, and the
stalk cell population was assessed by using phase-contrast microscopy. Data
are the mean±s.d. of three independent experiments. *P<0.05; **P<0.01
versus DMSO control; n.s., not significant (by one-tailed Welch’s t-test).
(B) Representative images of cells incubated for 48 h with the indicated
compounds. Arrowheads indicate stalk cells.
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chemotaxis via a RegA-dependent pathway (Kuwayama and
Kubohara, 2009; Kuwayama et al., 2011); we assume here that
DIF-1 functions via DR1-C (putative DIF-1 receptor responsible for
modulation of chemotaxis) and that DIF-2 functions via DR2-C
(putative DIF-2 receptor responsible for modulation of chemotaxis)
(Fig. 8A). DIF-1 is likely to modulate chemotaxis by interfering
with mitochondrial activity; if so, mitochondria might be the target
organelles of DIF-1 that contain DR1-C (Fig. 8B). CCCP and DNP
induce partial stalk cell differentiation (Fig. 6) and mitochondria
affect intracellular calcium and proton concentrations (Swietach
et al., 2013; de Marchi et al., 2014); therefore, DIF-1 might induce
stalk cell formation, at least in part, by disturbing (uncoupling)
mitochondrial activity (Fig. 8B,C).
MATERIALS AND METHODS
Cell lines and cell culture
The D. discoideum DIF-deficient strain HM44 (Kopachik et al., 1983) was
used for in vitro stalk cell induction assay. The axenic strain Ax2 and the
gbpB null strain gbpB– derived from Ax2 (Bosgraaf et al., 2002a,b;
Goldberg et al., 2002) were used for chemotaxis assay. These strains were
obtained from the National BioResource Project (NBRP Nenkin, Tsukuba,
Japan). HM44 cells were grown in association with Klebsiella aerogenes on
a modified SM agar plate (Inouye, 1988) at 21°C, whereas Ax2 and gbpB–
cells were grown axenically at 21°C in HL-5 liquid medium (Sussman,
1987). Growing cells were collected by centrifugation (500× g, 3 min).
Reagents
DIF-1, DIF-2, and Bu-BODIPY (Fig. 1A) were synthesized as described
previously (Gokan et al., 2005; Kubohara et al., 2013); they were
dissolved in ethanol or dimethyl sulfoxide (DMSO) and stored at −20°C.
Amino derivative of DIF-1 [6-amino-1-(3,5-dichloro-2,6-dihydroxy-4-
methoxyphenyl)hexan-1-one (DIF-1-NH2)] (Fig. 1B) was synthesized as
described previously (Kubohara et al., 2010). MitoTracker Red CMXRos
(referred to as MitoTracker) (Ex=579 nm, Em=599 nm) and BODIPY FL,
SE (succinimidyl ester) (Ex=505 nm, Em=513 nm) were purchased from
Invitrogen. Hoechst 33342 (Ex=352 nm, Em=461 nm) solution
(1 mg ml−1 in H2O), CCCP, and DNP were obtained from Wako Pure
Chemical Industries (Osaka, Japan). NBD-F (4-fluoro-7-nitro-2,1,3-
benzoxadiazole) (Ex=470 nm, Em=530 nm) was from Tokyo Chemical
Industry Co., Ltd. (Tokyo, Japan).
Synthesis of DIF-1-BODIPY
As depicted in Fig. 1B, DIF-1-NH2 (1.3 mg, 3.5 µmol) and triethylamine
(10 µl) were added to a solution of BODIPY FL, SE (2.1 mg, 5.3 µmol) inN,
N-dimethylformamide (0.5 ml) at room temperature (rt in Fig. 1B) in the dark.
The reaction mixture was stirred for 12 h and then diluted with 0.2 M
hydrochloric acid (5 ml) and extracted with ethyl acetate (10 ml) three times.
The residue was subjected to recycle preparative high-performance liquid
chromotography (HPLC) on a JAIGEL-GS-310 column (φ 20 mm×500 mm)
(Japan Analytical Industry Co., Ltd., Tokyo, Japan) in chloroform to give
DIF-1-BODIPY (1.2 mg, 2.0 µmol). Analytical data for DIF-1-BODIPY: 1H
nuclear magnetic resonance (NMR) [400 MHz, deuterated chloroform
Fig. 7. Effects of DIF-1-BODIPY, CCCP,
and DNP on chemotaxis toward cAMP.
Ax2 and gbpB– cells were starved for 6 h,
and cell droplets were placed on
phosphate-buffered agar containing 3 mM
caffeine (control) plus (A) DIF-1, DIF-2, or
DIF-1-BODIPY (DIF-1-BOD) or (B) DIF-1,
DIF-2, CCCP, or DNP. Cells were assayed
for chemotaxis at the indicated
concentrations of cAMP (10 cell droplets
per concentration per plate were
examined). Data are the mean±s.d. for
triplicate sample plates. *P<0.05; **P<0.01
versus control cells (by one-tailed Welch’s
t-test).
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(CDCl3)] δ 10.75–10.92 (1H, br.s), 7.08 (1H, s), 6.88 (1H, d, J=4.0 Hz), 6.30
(1H, d, J=4.0 Hz), 6.11 (1H, s), 5.80–5.88 (1H, br.s), 3.98 (3H, s), 3.28 (2H, t,
J=7.4 Hz), 3.23 (2H, q, J=6.9 Hz), 3.05 (2H, t, J=7.6 Hz), 2.66 (2H, t,
J=7.4 Hz), 2.56 (3H, s), 2.24 (3H, s), 1.67 (2H, quint, J=7.4 Hz), 1.47 (2H,
quint, J=7.4 Hz), 1.36 (2H, quint, J=7.4 Hz); high resolution fast-atom
bombardment mass spectrometry (HRFABMS) m/z 577.1645 [M-F]+
(577.1640 calculated for C27H30N3O5B35Cl2F).
Synthesis of DIF-1-NBD
DIF-1-NBD was synthesized as follows (Fig. 1C). To a solution of 2,6-bis
(benzyloxy)-4-methoxybenzoic acid (Kikuchi et al., 2008) (100 mg,
0.274 mmol) in dichloromethane (8.0 ml), 2-(trimethylsilyl)ethyl 2-
aminoethylcarbamate (61.3 mg, 0.300 mmol), O-(7-aza-1H-benzotriazol-1-
yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate (HATU) (103 mg,
0.274 mmol) and N,N-diisopropylethylamine (71 µl, 0.407 mmol) were
added at room temperature (rt in Fig. 1C). The reaction mixture was stirred
for 1 h, poured into water and extracted with ethyl acetate three times. The
combined organic layer was washed with water and brine, dried over sodium
sulfate and concentrated in vacuo. The residue was chromatographed over
silica gel elutedwith hexane–ethyl acetate (1:1) to give 2-(trimethylsilyl)ethyl
2-(2,6-bis(benzyloxy)-4-methoxyphenylamido)ethylcarbamate (106 mg,
0.192 mmol, 70% yield).
Fig. 8. Proposed scheme for DIF signaling pathways in D. discoideum. (A) Hypothetical receptors for DIF-1 and DIF-2 control cell differentiation and
chemotaxis. We assume that DIF-1 has two receptors: DR1-D (DR-1 in Kuwayama et al., 2011) and DR1-C (DR-2 in Kuwayama et al., 2011); DIF-2 has one
receptor, DR2-C (DR-3 in Kuwayama et al., 2011). We hypothesize that (1) DIF-1 induces stalk cell differentiation via DR1-D (DIF-1 receptor responsible for
induction of cell differentiation) and an increase in cytosolic calcium and proton concentrations (Kubohara and Okamoto, 1994; Kubohara et al., 2007); (2) DIF-1
suppresses chemotactic cell movement in shallow cAMP gradients via DR1-C (DIF-1 receptor responsible for modulation of chemotaxis) and the GbpB-
dependent pathway; and (3) DIF-2 promotes chemotactic cell movement in shallow cAMP gradients via DR2-C (DIF-2 receptor responsible for modulation of
chemotaxis) and the Dictyostelium histidine kinase C (DhkC)-RegA-dependent pathway (Kuwayama and Kubohara, 2016, 2009; Kuwayama et al., 2011). DhkC
might function as DR2-C (Kuwayama and Kubohara, 2016). DIF-2 would also induce stalk cell differentiation via DR1-D (dotted arrow) due to its structural
similarity to DIF-1. (B) Newly proposed scheme for chemotaxis modulation by DIF-1. DIF-1 localizes to mitochondria and suppresses chemotaxis in shallow
cAMP gradients. Because CCCP and DNP, similar to DIF-1, suppress chemotaxis in shallow cAMP gradients, DIF-1 might suppress chemotactic cell movement
via mitochondria and the GbpB-dependent pathway; DR1-C might reside in mitochondria. (C) Cellular localization of DIF-1 during early cell differentiation. In
vegetative cells, DIF-1 penetrates the cell membrane but is continuously pumped out of the cells; in differentiating (aggregating) cells, DIF-1 is retained in some
cells because of inactivation or disappearance of the pump. It is localized to mitochondria and promotes stalk cell differentiation.
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The latter (76.4 mg, 0.139 mmol) was stirred with 20% (w/w) palladium
hydroxide on carbon (10.0 mg) in methanol (2.0 ml) at room temperature
for 2 h under hydrogen atmosphere. After filtration through a celite pad, the
filtrate was concentrated in vacuo. The residue was chromatographed over
silica gel eluted with hexane–ethyl acetate (2:1) to afford 2-(trimethylsilyl)
ethyl 2-(2,6-dihydroxy-4-methoxyphenylamido)ethylcarbamate (45.7 mg,
0.124 mmol, 89% yield).
To a solution of the latter (45.0 mg, 0.121 mmol) in N,N-
dimethylformamide (1.5 ml), chloromethyl methyl ether (36 μl,
0.474 mmol) and potassium carbonate (51.1 mg, 0.370 mmol) were added
at room temperature. The reaction mixture was stirred for 8 h, poured into
water, and extracted with ethyl acetate three times. The combined organic
layer was washed with water and brine, dried over sodium sulfate, and
concentrated in vacuo. The residue was chromatographed over silica gel
eluted by hexane-ethyl acetate (2:1) to give 2-(trimethylsilyl)ethyl
2-(2-hydroxy-4-methoxy-6-(methoxymethoxy)phenylamido)ethylcarbamate
(41.9 mg, 0.101 mmol, 84% yield).
To a solution of the latter (40.0 mg, 0.096 mmol) in tetrahydrofuran (THF)
(1.5 ml), 1.0 M tetrabutylammonium fluoride in THF (100 µl, 0.100 mmol) was
added at room temperature. The reaction mixture was stirred for 1 h at
50°C, poured into water, and extracted with ethyl acetate three times. The
combined organic layer was washed with water and brine, dried over sodium
sulfate, and concentrated in vacuo. The residue was chromatographed over silica
gel eluted with chloroform–methanol (4:1) to giveN-(2-aminoethyl)-2-hydroxy-
4-methoxy-6-(methoxymethoxy)benzamide (17.2 mg, 0.063 mmol, 66% yield).
To a solution of the latter (15.0 mg, 0.056 mmol) in THF (1.5 ml), NBD-F
(20.5 µl, 0.112 mmol) and N,N-diisopropylethylamine (40 μl, 0.230 mmol)
were added at room temperature. The reaction mixture was stirred for 2 h,
poured into water, and extracted with ethyl acetate three times. The combined
organic layer was washed with water and brine, dried over sodium sulfate
and concentrated in vacuo. The residue was chromatographed over silica gel
eluted with hexane–ethyl acetate (1:1) to give 2-hydroxy-4-methoxy-6-
(methoxymethoxy)-N-(2-(7-nitrobenzo[c][1,2,5]oxadiazol-4-ylamino)ethyl)
benzamide (13.8 mg, 0.032 mmol, 57% yield).
The latter (9.3 mg, 0.021 mmol) was dissolved in 5% (w/v) HCl in
methanol (3.0 ml) at room temperature. The solution was stirred for 5 h and
concentrated in vacuo. The residue was dissolved in chloroform (1.5 ml),
and ethanol (30 µl) and sulfuryl chloride (8.0 mg, 0.059 mmol) were added
at room temperature. The reaction mixture was stirred for 2 h and
concentrated in vacuo. The residue was chromatographed over silica gel
eluted with chloroform–methanol (49:1) to give DIF-1-NBD [6.4 mg,
0.014 mmol, 65% yield (two steps)]. Analytical data for DIF-1-NBD: 1H
NMR (600 MHz, pyridine-d5) δ 11.08 (1H, s), 10.59 (1H, s), 8.61 (1H, d,
J=8.4 Hz), 6.41 (1H, d, J=8.4 Hz), 3.89–3.98 (4H, m), 3.91 (3H, s); 13C
NMR (150 MHz, pyridine-d5) δ 169.0, 159.5, 157.6 (2C), 144.4, 139.9,
137.5, 131.5, 120.4, 105.1 (2C), 103.6, 95.5, 60.8, 42.3, 38.8; HRFABMS
m/z 456.0085 [M-H]+ (456.0114 calculated for C16H12N5O735Cl2).
Low-magnification phase-contrast and fluorescence
microscopy
StarvedHM44 orAx2 cells were incubated for the indicated times with 1.5 ml
of the stalk salt solution [2 mMNaCl, 10 mMKCl, 1 mMCaCl2, 50 µg ml−1
penicillin, 100 µg ml−1 streptomycin sulfate and 10 mM 2-
morpholinoethanesulfonic acid-KOH (MES-KOH) pH 6.2 containing
various additives (DIF-1, DIF-1-BODIPY, Bu-BODIPY, DIF-1-NBD, and/
or cAMP) in 35-mm tissue culture dishes (Becton Dickinson, Franklin Lakes,
NJ, USA) (5×105 to 106 cells/dish). The cells werewashed three timeswith the
stalk salt solution and submerged in 1.5 ml of the same solution. The cells
were observed at room temperature with a Leica DM IRB fluorescence
microscope (Leica, Wetzlar, Germany), and digitized images were analyzed
with the Leica Application Suite (version 3.3.0).
Alternatively, cells were incubated for the indicated times with
additives (DIF-1 and/or cAMP) and fixed for 15–20 min at room
temperature in 2 ml of 3.7% (v/v) formaldehyde in PBS(–) (20 mM
phosphate buffered saline, pH 7.4), washed three times in PBS(–),
stained for 30 min with DIF-1-BODIPY, Bu-BODIPY, or DIF-1-NBD,
washed three times with PBS(–), and observed at room temperature
under the same microscope.
Multi-color imaging of formalin-fixed cells
Starved HM44 cells were incubated at 21°C for 1 h with 1.5 ml of the stalk
salt solution containingMitoTracker (0.2 µM) in 35-mm µ-Dishes (ib81156;
ibidi, Martinsried, Germany) (5×105 cells/dish). Alternatively, starved
HM44 cells were incubated for 20 h with 1.5 ml of the stalk salt solution
containing 5 mM cAMP in 35-mm plastic dishes (5×105 cells/dish) and then
for 1 h with the same solution containing MitoTracker (0.2 µM). Cells were
fixed for 15–20 min at room temperature with 2 ml of 3.7% (v/v)
formaldehyde in PBS(–), washed three times with PBS(–), and stained for
30 min with Hoechst 33342 (1 µg ml−1) and DIF-1-BODIPY (5 µM) or
Bu-BODIPY (5 µM). Cells were washed three times with PBS(–),
submerged in 1.5 ml of PBS(–) and observed at room temperature with a
Keyence BZ-9000 fluorescence microscope (Keyence, Osaka, Japan)
equipped with an oil immersion 100× lens (CFI Plan Apo VC100XH)
(Keyence) and multi-filters that can distinguish up to four fluorescent probes
simultaneously. The original photos were deconvoluted using the Keyence
BZ analyzer software to reduce ‘haze’. Z-stack sections were collected at
0.4-µm intervals, and the deconvoluted images were compiled into three-
dimensional (3D) images. All color images are presented in pseudo-colors.
In vitro stalk cell induction
Starved HM44 cells (2×105 cells/well) were differentiated at 21°C in 12-well
plates; each well was filled with 0.5 ml of stalk salt solution containing 5 mM
cAMP and additives (DIF-1, DIF-2, DIF-1-BODIPY, Bu-BODIPY, DIF-1-
NBD, DNP, and/or CCCP). At 48 h, the percentage of stalk cells among total
cells (>150 cells/dish) was assessed by using phase-contrast microscopy.
Small-population assay of chemotaxis
Chemotaxis toward cAMP was assessed by using Ax2 and gbpB– strains
in the presence of additives as described previously (Kuwayama and
Kubohara, 2009, 2016; Kuwayama et al., 2011).
Hydrophobic index
To estimate the membrane permeability of each compound, its hydrophobic
index (CP) (Fig. 1) was calculated by using ChemDraw10.0 software
(Cambridgesoft, Cambridge, MA, USA).
Statistical analysis
Unpaired Welch’s t-test (one-tailed) was used. P<0.05 was considered to
indicate significant differences.
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